natgillin/translations-raw huggingface dataset:
Clinical utility of a genetic test shall be an essential criterion for deciding to offer this test to a person or a group of persons.
Klinična korist genetskih testov mora biti temeljno merilo pri odločanju, ali naj se neki osebi ali skupini oseb ponudi to testiranje.
1 A genetic test for health purposes may only be performed under individualised medical supervision.
1 Genetski test za zdravstvene namene se sme opraviti le pod individualiziranim zdravniškim nadzorom.
2 Exceptions to the general rule referred to in paragraph 1 may be allowed by a Party, subject to appropriate measures being provided, taking into account the way the test will be carried out, to give effect to the other provisions of this Protocol.
2 Pogodbenica lahko dovoli odstopanje od splošnega pravila iz prvega odstavka, če so ob upoštevanju načina izvedbe testa zagotovljeni ustrezni ukrepi, ki omogočajo izvajanje drugih določb tega protokola.
However, such an exception may not be made with regard to genetic tests with important implications for the health of the persons concerned or members of their family or with important implications concerning procreation choices.
Tako odstopanje pa ni dopustno pri genetskih testih s pomembnim vplivom na zdravje zadevnih oseb ali njihovih družinskih članov oziroma s pomembnim vplivom na odločanje glede izbire pri oploditvi.
1 When a genetic test is envisaged, the person concerned shall be provided with prior appropriate information in particular on the purpose and the nature of the test, as well as the implications of its results.
1 Kadar se predvideva genetsko testiranje, se zadevni osebi predhodno dajo ustrezne informacije, zlasti še o namenu in naravi testiranja ter posledicah dobljenih izsledkov.
2 For predictive genetic tests as referred to in Article 12 of the Convention on Human Rights and Biomedicine, appropriate genetic counselling shall also be available for the person concerned.
2 Pri napovednih genetskih testih iz 12. člena Konvencije o človekovih pravicah v zvezi z biomedicino mora biti zadevni osebi na razpolago tudi ustrezno genetsko svetovanje.
The form and extent of this genetic counselling shall be defined according to the implications of the results of the test and their significance for the person or the members of his or her family, including possible implications concerning procreation choices.
Oblika in obseg tega genetskega svetovanja se določata glede na posledice izsledkov testa in njihov pomen za zadevno osebo ali njene družinske člane, vključno z mogočim vplivom na odločanje glede izbire pri oploditvi.
Genetic counselling shall be given in a non-directive manner.
Genetsko svetovanje se izvaja na način, ki ni usmerjajoč.
1 A genetic test may only be carried out after the person concerned has given free and informed consent to it.
1 Genetsko testiranje se sme izvesti le, če je zadevna oseba vanj prostovoljno privolila na podlagi prejetih pojasnil.
Consent to tests referred to in Article 8, paragraph 2, shall be documented.
Privolitev v testiranje iz drugega odstavka 8. člena se dokumentira.
2 The person concerned may freely withdraw consent at any time.
2 Zadevna oseba lahko svojo privolitev kadar koli svobodno prekliče.
Subject to Article 13 of this Protocol, a genetic test on a person who does not have the capacity to consent may only be carried out for his or her direct benefit.
Ob upoštevanju 13. člena tega protokola se sme opraviti genetski test pri osebi, ki ni sposobna dati privolitve, samo kadar je to v njeno neposredno korist.
Where, according to law, a minor does not have the capacity to consent, a genetic test on this person shall be deferred until attainment of such capacity unless that delay would be detrimental to his or her health or well-being.
Kadar v skladu z zakonom mladoletna oseba ni sposobna dati privolitve, se genetski test pri njej odloži, dokler ne postane opravilno sposobna, razen če bi tak odlog škodil njenemu zdravju ali dobrobiti.
1 When a genetic test is envisaged in respect of a person not able to consent, the person, authority or body whose authorisation is required shall be provided with prior appropriate information in particular with regard to the purpose and the nature of the test, as well as the implications of its results.
1 Kadar se predvideva genetsko svetovanje pri osebi, ki ni sposobna dati privolitve, se osebi, zavodu ali organu, katerega dovoljenje je potrebno, predhodno dajo ustrezne informacije, zlasti še o namenu in naravi testiranja ter posledicah dobljenih izsledkov.
Appropriate prior information shall also be provided to the person not able to consent in respect of whom the test is envisaged, to the extent of his or her capacity to understand.
Osebi, pri kateri je predvideno testiranje in ni sposobna dati privolitve, se da ustrezna predhodna informacija v obsegu, ki ustreza njeni zmožnosti razumevanja.
A qualified person shall be available to answer possible questions by the person, authority or body whose authorisation is required, and, if appropriate, the person in respect of whom the test is envisaged.
Na razpolago mora biti usposobljena oseba, da odgovarja na morebitna vprašanja osebe, zavoda ali organa, katerega dovoljenje je potrebno, in če je primerno, tudi osebe, pri kateri je predvideno testiranje.
2 The provisions of Article 8, paragraph 2, shall apply in the case of persons not able to consent to the extent of their capacity to understand.
2 Za osebe, ki niso sposobne dati privolitve, določbe drugega odstavka 8. člena veljajo v obsegu, ki ustreza njihovi zmožnosti razumevanja.
Where relevant, appropriate support shall be available for the person whose authorisation is required.
Kadar je to pomembno, mora biti na razpolago ustrezna podpora osebi, katere dovoljenje je potrebno.
1 Where, according to law, a minor does not have the capacity to consent to a genetic test, that test may only be carried out with the authorisation of his or her representative or an authority or a person or body provided for by law.
1 Kadar v skladu z zakonom mladoletna oseba ni sposobna privoliti v genetsko testiranje, se to lahko opravi le z dovoljenjem njenega zastopnika ali zavoda ali osebe ali organa, kakor je določeno z zakonom.
The opinion of the minor shall be taken into consideration as an increasingly determining factor in proportion to his or her age and degree of maturity.
Pri tem je treba upoštevati mnenje mladoletne osebe, ki je toliko bolj zavezujoče, kolikor starejša in zrelejša je ta oseba.
2 Where, according to law, an adult does not have the capacity to consent to a genetic test because of a mental disability, a disease or for similar reasons, that test may only be carried out with the authorisation of his or her representative or an authority or a person or body provided for by law.
2 Kadar v skladu z zakonom odrasla oseba ni sposobna privoliti v genetsko testiranje zaradi zmanjšane duševne zmožnosti, bolezni ali podobnih razlogov, se to lahko opravi le z dovoljenjem njenega zastopnika ali zavoda ali osebe ali organa, kakor je določeno z zakonom.
Wishes relating to a genetic test expressed previously by an adult at a time where he or she had capacity to consent shall be taken into account.
Želje glede genetskega testiranja, ki jih je odrasla oseba izrazila, ko je še bila sposobna dati privolitev, se upoštevajo.
The individual concerned shall, to the extent of his or her capacity to understand, take part in the authorisation procedure.
Zadevni posameznik glede na svoje zmožnosti razumevanja sodeluje v postopku pridobitve dovoljenja.
3 Authorisation to tests referred to in Article 8, paragraph 2, shall be documented.
3 Dovoljenje k testom iz drugega odstavka 8. člena se dokumentira.
4 The authorisation referred to in paragraphs 1 and 2 above may be withdrawn at any time in the best interests of the person concerned.
4 Dovoljenje iz prvega in drugega odstavka tega člena je mogoče kadar koli preklicati, če je to v korist zadevne osebe.
Exceptionally, and by derogation from the provisions of Article 6, paragraph 1, of the Convention on Human Rights and Biomedicine and of Article 10 of this Protocol, the law may allow a genetic test to be carried out, for the benefit of family members, on a person who does not have the capacity to consent, if the following conditions are met:
Izjemoma in z odstopanjem od določb prvega odstavka 6. člena Konvencije o človekovih pravicah v zvezi z biomedicino in 10. člena tega protokola je po zakonu lahko dovoljeno opraviti genetski test pri osebi, ki ni sposobna dati privolitve, kadar je to v korist družinskih članov, če so izpolnjeni naslednji pogoji:
a the purpose of the test is to allow the family member(s) concerned to obtain a preventive, diagnostic or therapeutic benefit that has been independently evaluated as important for their health, or to allow them to make an informed choice with respect to procreation;
a namen testa je omogočiti zadevnemu družinskemu članu ali članom preventivno, diagnostično ali terapevtsko korist, ki je po neodvisni oceni pomembna za njihovo zdravje, ali jim omogočiti, da sprejmejo odločitev glede izbire pri oploditvi na podlagi prejetih pojasnil;
b the benefit envisaged cannot be obtained without carrying out this test;
b predvidena korist se ne da doseči brez tega testa;
c the risk and burden of the intervention are minimal for the person who is undergoing the test;
c tveganje in breme posega sta za osebo, pri kateri se opravi ta test, minimalni;
d the expected benefit has been independently evaluated as substantially outweighing the risk for private life that may arise from the collection, processing or communication of the results of the test;
d po neodvisni oceni pričakovane koristi bistveno presegajo tveganje za zasebno življenje, do katerega bi lahko prišlo zaradi zbiranja, obdelave ali sporočanja izsledkov testiranja;
e the authorisation of the representative of the person not able to consent, or an authority or a person or body provided for by law has been given;
e pri osebi, ki ni sposobna dati privolitve, je dovoljenje dal njen zakoniti zastopnik ali zavod ali oseba ali organ, kakor je določeno z zakonom;
f the person not able to consent shall, in proportion to his or her capacity to understand and degree of maturity, take part in the authorisation procedure.
f oseba, ki ni sposobna dati privolitve, skladno s svojimi zmožnostmi razumevanja sodeluje v postopku pridobitve dovoljenja.
The test shall not be carried out if this person objects to it.
Test se ne opravi, če ta oseba temu nasprotuje.
When it is not possible, with reasonable efforts, to contact a person for a genetic test for the benefit of his or her family member(s) on his or her biological material previously removed for another purpose, the law may allow the test to be carried out in accordance with the principle of proportionality, where the expected benefit cannot be otherwise obtained and where the test cannot be deferred.
Kadar kljub smiselnim prizadevanjem ni mogoče vzpostaviti stika z osebo za izvedbo genetskega testa v njeno korist ali korist njenih družinskih članov na njenem biološkem materialu, odvzetem predhodno za kak drug namen, je zakonsko dopustno opraviti testiranje v skladu z načelom sorazmernosti, kadar pričakovane koristi ni mogoče doseči kako drugače in se test ne da odložiti.
Provisions shall be made, in accordance with Article 22 of the Convention on Human Rights and Biomedicine, for the case where the person concerned has expressly opposed such test.
Skladno z 22. členom Konvencije o človekovih pravicah v zvezi z biomedicino se predvidi tudi možnost, kadar zadevna oseba izrecno nasprotuje takemu testiranju.
A genetic test for the benefit of other family members may be carried out on biological samples:
Genetski test v korist drugih družinskih članov se lahko opravi na bioloških vzorcih:
1 Everyone has the right to respect for his or her private life, in particular to protection of his or her personal data derived from a genetic test.
1 Vsakdo ima pravico do spoštovanja svojega zasebnega življenja, zlasti še do varovanja svojih osebnih podatkov v zvezi z genetskimi testi.
2 Everyone undergoing a genetic test is entitled to know any information collected about his or her health derived from this test.
2 Vsakdo, pri katerem se opravi genetski test, ima pravico do katerih koli informacij o svojem zdravju, ki so bile zbrane s pomočjo tega testa.
The conclusions drawn from the test shall be accessible to the person concerned in a comprehensible form.
Ugotovitve na podlagi tega testa morajo biti zadevni osebi dostopne v razumljivi obliki.
3 The wish of a person not to be informed shall be respected.
3 Željo osebe, ki ne želi biti obveščena, je treba spoštovati.
4 In exceptional cases, restrictions may be placed by law on the exercise of the rights contained in paragraphs 2 and 3 above in the interests of the person concerned.
4 Izjemoma se lahko v korist zadevne osebe zakonsko omeji uveljavljanje pravic iz drugega in tretjega odstavka tega člena.
Where the results of a genetic test undertaken on a person can be relevant to the health of other family members, the person tested shall be informed.
Kadar so lahko izsledki genetskega testa, opravljenega pri neki osebi, pomembni za zdravje drugih družinskih članov, je treba testirano osebo o tem obvestiti.
A health screening programme involving the use of genetic tests may only be implemented if it has been approved by the competent body.
Zdravstveni program presejanja, ki vključuje uporabo genetskih testov, se sme izvajati, samo če ga je odobril pristojni organ.
This approval may only be given after independent evaluation of its ethical acceptability and fulfilment of the following specific conditions:
Ta odobritev pa lahko temelji samo na neodvisni oceni etične sprejemljivosti in izpolnjevanja teh posebnih pogojev:
a the programme is recognised for its health relevance for the whole population or section of population concerned;
a program je priznan kot pomemben za zdravje celotnega prebivalstva ali dela zadevnega prebivalstva;
b the scientific validity and effectiveness of the programme have been established;
b ugotovljeni sta znanstvena veljavnost in učinkovitost programa;
c appropriate preventive or treatment measures in respect of the disease or disorder which is the subject of the screening, are available to the persons concerned;
c zadevni osebi so na razpolago ustrezni preventivni ali terapevtski ukrepi za bolezen ali motnjo, ki je predmet presejanja;
d appropriate measures are provided to ensure equitable access to the programme;
d na razpolago so ustrezni ukrepi za zagotavljanje enakopravnega dostopa do programa;
e the programme provides measures to adequately inform the population or section of population concerned of the existence, purposes and means of accessing the screening programme as well as the voluntary nature of participation in it.
e program vključuje ukrepe za ustrezno obveščanje prebivalstva ali dela zadevnega prebivalstva o obstoju in namenu programa presejanja ter načinu dostopa do njega in o prostovoljni naravi sodelovanja v njem.
Parties shall take appropriate measures to facilitate access for the public to objective general information on genetic tests, including their nature and the potential implications of their results.
Pogodbenice sprejmejo ustrezne ukrepe, da javnosti omogočijo dostop do objektivnih splošnih informacij o genetskih testih, vključno z njihovo naravo in mogočimi posledicami njihovih izsledkov.
As between the Parties, the provisions of Articles 1 to 20 of this Protocol shall be regarded as additional articles to the Convention on Human Rights and Biomedicine, and all the provisions of the Convention shall apply accordingly.
Med pogodbenicami velja, da se vse določbe od 1. do 20. člena tega protokola obravnavajo kot dodatni členi Konvencije o človekovih pravicah v zvezi z biomedicino, vse določbe konvencije pa se uporabljajo skladno s tem.
None of the provisions of this Protocol shall be interpreted as limiting or otherwise affecting the possibility for a Party to grant persons concerned by genetic testing for health purposes a wider measure of protection than is stipulated in this Protocol.
Nobena določba tega protokola se ne razlaga, kot da omejuje ali drugače vpliva na možnost pogodbenice, da osebam, na katere se nanaša genetsko testiranje za zdravstvene namene, zagotovi večje varstvo, kot je določeno v tem protokolu.
In order to monitor scientific developments, the present Protocol shall be examined within the Committee referred to in Article 32 of the Convention on Human Rights and Biomedicine no later than five years from the entry into force of this Protocol and thereafter at such intervals as the Committee may determine.
Da bi sledili razvoju znanosti, bo odbor, imenovan v 32. členu Konvencije o človekovih pravicah v zvezi z biomedicino, ponovno presodil ustreznost protokola najpozneje pet let po začetku njegove veljavnosti, nato pa v takih presledkih, kot bo določil odbor.
This Protocol shall be open for signature by Signatories to the Convention on Human Rights and Biomedicine.
Protokol je na voljo za podpis podpisnicam Konvencije o človekovih pravicah v zvezi z biomedicino.
2 In respect of any Signatory which subsequently expresses its consent to be bound by it, the Protocol shall enter into force on the first day of the month following the expiration of a period of three months after the date of the deposit of the instrument of ratification, acceptance or approval.
Za vsako podpisnico, ki pozneje privoli, da jo protokol zavezuje, začne ta veljati prvi dan meseca, ki sledi izteku trimesečnega obdobja po dnevu vložitve njene listine o ratifikaciji, sprejetju ali odobritvi.
2 Accession shall be effected by the deposit with the Secretary General of the Council of Europe of an instrument of accession which shall take effect on the first day of the month following the expiration of a period of three months after the date of its deposit.
2) Pristopi se z deponiranjem pristopne listine pri generalnem sekretarju Sveta Evrope, ki začne veljati prvi dan meseca po poteku treh mesecev od datuma deponiranja.
1 Any Party may at any time denounce this Protocol by means of a notification addressed to the Secretary General of the Council of Europe.
Vsaka pogodbenica lahko ta protokol kadar koli odpove z uradnim obvestilom, naslovljenim na generalnega sekretarja Sveta Evrope.
2 Such denunciation shall become effective on the first day of the month following the expiration of a period of three months after the date of receipt of such notification by the Secretary General.
Odpoved začne veljati prvi dan meseca po poteku treh mesecev po datumu, ko generalni sekretar prejme obvestilo.
The Secretary General of the Council of Europe shall notify the member States of the Council of Europe, the European Community, any Signatory, any Party and any other State which has been invited to accede to the Convention on Human Rights and Biomedicine of:
Generalni sekretar Sveta Evrope uradno obvesti države članice Sveta Evrope, Evropsko skupnost, vsako podpisnico, vsako pogodbenico in vsako drugo državo, ki je bila povabljena, da pristopi h Konvenciji o človekovih pravicah v zvezi z biomedicino, o:
c any date of entry into force of this Protocol in accordance with Articles 5 and 6;
c) vsakem datumu začetka veljavnosti tega protokola v skladu s 5. in 6. členom;
The Secretary General of the Council of Europe shall transmit certified copies to each member State of the Council of Europe, to the non-member States which have participated in the elaboration of this Protocol, to any State invited to accede to the Convention on Human Rights and Biomedicine and to the European Community.
Generalni sekretar Sveta Evrope pošlje overjene kopije državam članicam Sveta Evrope, državam nečlanicam, ki so sodelovale pri pripravi tega protokola, vsaki državi, ki je povabljena, da pristopi h Konvenciji o človekovih pravicah v zvezi z biomedicino, ter Evropski skupnosti.
The terms used in this Agreement shall have the following meaning:
Izrazi, uporabljeni v besedilu tega sporazuma, pomenijo:
on the supplementary supervision of credit institutions, insurance undertakings and investment firms in a financial conglomerate and amending Council Directives 73/239/EEC, 79/267/EEC, 92/49/EEC, 92/96/EEC, 93/6/EEC and 93/22/EEC, and Directives 98/78/EC and 2000/12/EC of the European Parliament and of the Council
o dopolnilnem nadzoru kreditnih institucij, zavarovalnic in investicijskih družb v finančnem konglomeratu, ki spreminja direktive Sveta 73/239/EGS, 79/267/EGS, 92/4. 9/EGS, 92/96/EGS, 93/6/EGS in 93/22/EGS ter direktivi 98/78/ES in 2000/12/ES Evropskega parlamenta in Sveta
(1) The current Community legislation provides for a comprehensive set of rules on the prudential supervision of credit institutions, insurance undertakings and investment firms on a stand alone basis and credit institutions, insurance undertakings and investment firms which are part of respectively a banking/investment firm group or an insurance group, i.e. groups with homogeneous financial activities.
(1) Veljavna zakonodaja Skupnosti predpisuje celovit niz pravil glede bonitetnega nadzora kreditnih institucij, zavarovalnic in investicijskih družb na soloosnovi ter kreditnih institucij, zavarovalnic in investicijskih družb, ki so del skupine bank, investicijskih družb ali zavarovalnic, to je skupin s homogenimi finančnimi dejavnostmi.
(2) New developments in financial markets have led to the creation of financial groups which provide services and products in different sectors of the financial markets, called financial conglomerates.
(2) Napredek na finančnih trgih je privedel do ustanavljanja finančnih skupin, ki opravljajo storitve in prodajajo izdelke v različnih sektorjih finančnih trgov in se imenujejo finančni konglomerati.
Until now, there has been no form of prudential supervision on a group-wide basis of credit institutions, insurance undertakings and investment firms which are part of such a conglomerate, in particular as regards the solvency position and risk concentration at the level of the conglomerate, the intra-group transactions, the internal risk management processes at conglomerate level, and the fit and proper character of the management.
Doslej ni bilo nobene oblike bonitetnega nadzora na ravni skupine kreditnih institucij, zavarovalnic in investicijskih podjetij, ki so del takih konglomeratov, zlasti glede kapitalskih zahtev in koncentracije tveganja na ravni konglomerata, poslov v skupini, notranjih postopkov upravljanja s tveganji na ravni konglomerata ter ustreznega in pravilnega upravljanja.
Some of these conglomerates are among the biggest financial groups which are active in the financial markets and provide services on a global basis.
Nekateri konglomerati so med največjimi finančnimi skupinami, ki poslujejo na finančnih trgih in opravljajo storitve po vsem svetu.
If such conglomerates, and in particular credit institutions, insurance undertakings and investment firms which are part of such a conglomerate, were to face financial difficulties, these could seriously destabilise the financial system and affect individual depositors, insurance policy holders and investors.
Če bi se ti konglomerati, zlasti kreditne institucije, zavarovalnice in investicijske družbe, ki so del takih konglomeratov, znašli v finančnih težavah, bi to lahko resno destabiliziralo finančni sistem in vplivalo na posamezne deponente, zavarovance in vlagatelje.